{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:48:45Z","timestamp":1793789325330,"version":"4.6.1"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1054312"],"award-info":[{"award-number":["1054312"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008639","name":"Sir Edward \u2018Weary\u2019 Dunlop Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001232","name":"Royal Australasian College of Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008713","name":"Diabetes Australia Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00225","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T04:15:34Z","timestamp":1526962534000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":61,"title":["Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Lauren","family":"Winter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia A.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Jerums","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jas-mine","family":"Seah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sih Min","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda T.","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"MacIsaac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif I.","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-8587(15)00261-2","article-title":"The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial","volume":"3","author":"de Zeeuw","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.ajkd.2011.09.017","article-title":"Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database","volume":"59","author":"Packham","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2147\/PPA.S85577","article-title":"Association of neutrophil\/lymphocyte ratio with obstructive coronary artery disease and coronary artery calcium score detected by multislice computed tomography in type 2 diabetes mellitus patients","volume":"9","author":"Aygun","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"B8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"Gross","year":"2005","journal-title":"Diabetes Care"},{"key":"B9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.diabres.2010.01.026","article-title":"Global healthcare expenditure on diabetes for 2010 and 2030","volume":"87","author":"Zhang","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"B10","first-page":"72","article-title":"Interleukin-6 and C-reactive protein in pathogenesis of diabetic nephropathy: new evidence linking inflammation, glycemic control, and microalbuminuria","volume":"2","author":"Choudhary","year":"2008","journal-title":"Iran J Kidney Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3109\/0886022X.2012.668741","article-title":"Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study)","volume":"34","author":"Azab","year":"2012","journal-title":"Ren Fail"},{"key":"B12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/MNH.0b013e3283456546","article-title":"Diabetic kidney disease with and without albuminuria","volume":"20","author":"MacIsaac","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/ki.2014.98","article-title":"Progressive diabetic nephropathy. How useful is microalbuminuria? contra","volume":"86","author":"MacIsaac","year":"2014","journal-title":"Kidney Int"},{"key":"B14","first-page":"34","volume-title":"The Shifting Paradigm of Albuminuria in Diabetic Kidney Disease","author":"Watts","year":"2015"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5812\/nephropathol.8966","article-title":"Prediction of diabetic nephropathy: the need for a sweet biomarker","volume":"2","author":"Tolouian","year":"2013","journal-title":"J Nephropathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1042\/CS20160636","article-title":"Diabetic nephropathy \u2013 is this an immune disorder?","volume":"131","author":"Tesch","year":"2017","journal-title":"Clin Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the immune response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s001250051058","article-title":"Is type II diabetes mellitus a disease of the innate immune system?","volume":"41","author":"Pickup","year":"1998","journal-title":"Diabetologia"},{"key":"B19","volume-title":"Molecular Biology of the Cell","author":"Alberts","year":"2015"},{"key":"B20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"Pickup","year":"2004","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1464-5491.2003.01030.x","article-title":"Type 2 diabetes mellitus: a disease of the innate immune system? An update","volume":"21","author":"Crook","year":"2004","journal-title":"Diabet Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0167-5699(94)90138-4","article-title":"The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein","volume":"15","author":"Steel","year":"1994","journal-title":"Immunol Today"},{"key":"B24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/1043-4666(92)90079-7","article-title":"Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein","volume":"4","author":"Ballou","year":"1992","journal-title":"Cytokine"},{"key":"B25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood.V82.2.513.513","article-title":"C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor","volume":"82","author":"Cermak","year":"1993","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1046\/j.1523-1755.2002.00378.x","article-title":"The T cell as a bridge between innate and adaptive immune systems: implications for the kidney","volume":"61","author":"Rabb","year":"2002","journal-title":"Kidney Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.jaci.2009.09.017","article-title":"Adaptive immunity","volume":"125","author":"Bonilla","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1007\/s001250050822","article-title":"NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X","volume":"40","author":"Pickup","year":"1997","journal-title":"Diabetologia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1053\/j.ajkd.2013.10.048","article-title":"Markers of and risk factors for the development and progression of diabetic kidney disease","volume":"63","author":"Macisaac","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1053\/euhj.2001.3052","article-title":"Do atherosclerosis and type 2 diabetes share a common inflammatory basis?","volume":"23","author":"Pradhan","year":"2002","journal-title":"Eur Heart J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.2337\/diacare.22.12.1971","article-title":"Body mass index, diabetes, and C-reactive protein among U.S. adults","volume":"22","author":"Ford","year":"1999","journal-title":"Diabetes Care"},{"key":"B35","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00125-002-0829-2","article-title":"Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors","volume":"45","author":"Muller","year":"2002","journal-title":"Diabetologia"},{"key":"B36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1900\/RDS.2007.4.98","article-title":"Association between low-grade systemic inflammation and type 2 diabetes mellitus among men and women from the ATTICA Study","volume":"4","author":"Pitsavos","year":"2007","journal-title":"Rev Diabet Stud"},{"key":"B37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2337\/diabetes.53.3.693","article-title":"Inflammatory markers and risk of developing type 2 diabetes in women","volume":"53","author":"Hu","year":"2004","journal-title":"Diabetes"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.2337\/diabetes.51.5.1596","article-title":"C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study","volume":"51","author":"Freeman","year":"2002","journal-title":"Diabetes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00125-004-1472-x","article-title":"C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men","volume":"47","author":"Laaksonen","year":"2004","journal-title":"Diabetologia"},{"key":"B41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.diabet.2012.03.004","article-title":"Effect of high-sensitivity C-reactive protein on the development of diabetes as demonstrated by pooled logistic-regression analysis of annual health-screening information from male Japanese workers","volume":"39","author":"Morimoto","year":"2013","journal-title":"Diabetes Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.2337\/diacare.25.11.2016","article-title":"Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study","volume":"25","author":"Han","year":"2002","journal-title":"Diabetes Care"},{"key":"B43","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2337\/dc06-1693","article-title":"Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA\/KORA Augsburg case-cohort study, 1984-2002","volume":"30","author":"Thorand","year":"2007","journal-title":"Diabetes Care"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.2337\/diacare.26.10.2754","article-title":"Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans","volume":"26","author":"Nakanishi","year":"2003","journal-title":"Diabetes Care"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.2337\/diabetes.50.10.2384","article-title":"The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study","volume":"50","author":"Barzilay","year":"2001","journal-title":"Diabetes"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2337\/diabetes.51.4.1131","article-title":"Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study","volume":"51","author":"Festa","year":"2002","journal-title":"Diabetes"},{"key":"B47","doi-asserted-by":"publisher","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","article-title":"Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study","volume":"52","author":"Spranger","year":"2003","journal-title":"Diabetes"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.2337\/diacare.28.10.2497","article-title":"Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study","volume":"28","author":"Doi","year":"2005","journal-title":"Diabetes Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2337\/db06-0922","article-title":"Genetic variation, C-reactive protein levels, and incidence of diabetes","volume":"56","author":"Dehghan","year":"2007","journal-title":"Diabetes"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s00125-009-1338-3","article-title":"Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis","volume":"52","author":"Lee","year":"2009","journal-title":"Diabetologia"},{"key":"B51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archinte.163.1.93","article-title":"C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998","volume":"163","author":"Thorand","year":"2003","journal-title":"Arch Intern Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.2337\/diacare.26.6.1745","article-title":"Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian","volume":"26","author":"Krakoff","year":"2003","journal-title":"Diabetes Care"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.2337\/diacare.28.7.1710","article-title":"Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis","volume":"28","author":"Chung","year":"2005","journal-title":"Diabetes Care"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.2337\/diacare.25.12.2354-a","article-title":"White blood cell count is positively correlated with albumin excretion rate in subjects with type 2 diabetes","volume":"25","author":"Cavalot","year":"2002","journal-title":"Diabetes Care"},{"key":"B55","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2337\/diacare.27.2.491","article-title":"Elevated white blood cell count in subjects with impaired glucose tolerance","volume":"27","author":"Ohshita","year":"2004","journal-title":"Diabetes Care"},{"key":"B56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/aje\/155.1.57","article-title":"Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults","volume":"155","author":"Ford","year":"2002","journal-title":"Am J Epidemiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2337\/diabetes.51.2.455","article-title":"High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes","volume":"51","author":"Vozarova","year":"2002","journal-title":"Diabetes"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/S0140-6736(99)01046-6","article-title":"Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study","volume":"353","author":"Schmidt","year":"1999","journal-title":"Lancet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.2337\/dc12-2572","article-title":"Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function","volume":"36","author":"Ekinci","year":"2013","journal-title":"Diabetes Care"},{"key":"B60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2337\/diacare.27.1.195","article-title":"Nonalbuminuric renal insufficiency in type 2 diabetes","volume":"27","author":"MacIsaac","year":"2004","journal-title":"Diabetes Care"},{"key":"B61","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2337\/diabetes.43.5.649","article-title":"Progressive decline in renal function in diabetic patients with and without albuminuria","volume":"43","author":"Tsalamandris","year":"1994","journal-title":"Diabetes"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2337\/diabetes.51.4.1157","article-title":"Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death","volume":"51","author":"Stehouwer","year":"2002","journal-title":"Diabetes"},{"key":"B63","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2337\/dc13-1870","article-title":"Microalbuminuria as a risk predictor in diabetes: the continuing saga","volume":"37","author":"Bakris","year":"2014","journal-title":"Diabetes Care"},{"key":"B64","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/BF00400732","article-title":"Albumin excretion and vascular deaths in NIDDM","volume":"38","author":"MacLeod","year":"1995","journal-title":"Diabetologia"},{"key":"B65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.diabres.2004.02.009","article-title":"Acute-phase proteins and microalbuminuria among patients with type 2 diabetes","volume":"66","author":"Gomes","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1046\/j.1523-1755.2000.00331.x","article-title":"Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study","volume":"58","author":"Festa","year":"2000","journal-title":"Kidney Int"},{"key":"B67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s592-001-8072-5","article-title":"Lack of an association of urinary albumin excretion with interleukin-6 or C-reactive protein in patients with type 2 diabetes","volume":"38","author":"Otto","year":"2001","journal-title":"Acta Diabetol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1053\/meta.2003.50096","article-title":"Elevated levels of interleukin-18 and tumor necrosis factor-\u03b1 in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy","volume":"52","author":"Moriwaki","year":"2003","journal-title":"Metabolism"},{"key":"B69","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1681\/ASN.2004110961","article-title":"Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes","volume":"16","author":"Dalla Vestra","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1042\/cs1000591","article-title":"Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats","volume":"100","author":"Cao","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"B71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12933-016-0359-8","article-title":"Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes","volume":"15","author":"Carlsson","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ki.2015.278","article-title":"Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes","volume":"89","author":"Pavkov","year":"2016","journal-title":"Kidney Int"},{"key":"B73","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ki.2014.330","article-title":"Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes","volume":"87","author":"Pavkov","year":"2015","journal-title":"Kidney Int"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.2337\/diacare.26.5.1439","article-title":"Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT\/EDIC cohort","volume":"26","author":"Klein","year":"2003","journal-title":"Diabetes Care"},{"key":"B75","doi-asserted-by":"publisher","first-page":"974","DOI":"10.2337\/dc07-2101","article-title":"C-reactive protein in relation to the development of microalbuminuria in type 1 diabetes: the Oxford Regional Prospective Study","volume":"31","author":"Marcovecchio","year":"2008","journal-title":"Diabetes Care"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1007\/s00125-003-1194-5","article-title":"Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients","volume":"46","author":"Saraheimo","year":"2003","journal-title":"Diabetologia"},{"key":"B77","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s001250051162","article-title":"Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation","volume":"42","author":"Schalkwijk","year":"1999","journal-title":"Diabetologia"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.2337\/dc07-1960","article-title":"Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate","volume":"31","author":"Astrup","year":"2008","journal-title":"Diabetes Care"},{"key":"B79","first-page":"91","article-title":"Soluble intercellular adhesion molecule-1 (sICAM-1): an overview","volume":"15","author":"Witkowska","year":"2004","journal-title":"Eur Cytokine Netw"},{"key":"B80","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/ki.2014.212","article-title":"Markers of endothelial dysfunction and inflammation predict progression of diabetic nephropathy in African Americans with type 1 diabetes","volume":"87","author":"Roy","year":"2015","journal-title":"Kidney Int"},{"key":"B81","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1365-2796.2000.00705.x","article-title":"Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors","volume":"248","author":"Lechleitner","year":"2000","journal-title":"J Intern Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2215\/CJN.03010608","article-title":"Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes","volume":"4","author":"Niewczas","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.2337\/dc13-1983","article-title":"Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria","volume":"37","author":"Skupien","year":"2014","journal-title":"Diabetes Care"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2337\/diacare.26.7.2165","article-title":"Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study","volume":"26","author":"Schram","year":"2003","journal-title":"Diabetes Care"},{"key":"B85","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1464-5491.2005.01562.x","article-title":"Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy","volume":"22","author":"Targher","year":"2005","journal-title":"Diabet Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin Nephrol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.molimm.2011.04.014","article-title":"Inhibiting the C5-C5a receptor axis","volume":"48","author":"Woodruff","year":"2011","journal-title":"Mol Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"B90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrneph.2017.31","article-title":"The role of the complement system in diabetic nephropathy","volume":"13","author":"Flyvbjerg","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0272-6386(87)80089-6","article-title":"Ultrastructural localization of the membrane attack complex of complement in human renal tissues","volume":"9","author":"Falk","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2337\/diabetes.53.10.2653","article-title":"Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes","volume":"53","author":"Qin","year":"2004","journal-title":"Diabetes"},{"key":"B93","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1053\/j.ajkd.2004.04.027","article-title":"Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation","volume":"44","author":"Uesugi","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.2337\/diabetes.53.6.1570","article-title":"Association between mannose-binding lectin and vascular complications in type 1 diabetes","volume":"53","author":"Hansen","year":"2004","journal-title":"Diabetes"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.2337\/diabetes.54.5.1523","article-title":"Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study","volume":"54","author":"Hovind","year":"2005","journal-title":"Diabetes"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s00125-014-3332-7","article-title":"Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up study","volume":"57","author":"Ostergaard","year":"2014","journal-title":"Diabetologia"},{"key":"B97","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/sji.12027","article-title":"Diabetes-induced changes in mannan-binding lectin levels and complement activation in a mouse model of type 1 diabetes","volume":"77","author":"Ostergaard","year":"2013","journal-title":"Scand J Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1210\/jc.2003-030742","article-title":"Elevated levels of mannan-binding lectin in patients with type 1 diabetes","volume":"88","author":"Hansen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B99","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00125-004-1594-1","article-title":"Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy","volume":"48","author":"Saraheimo","year":"2005","journal-title":"Diabetologia"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.2337\/db08-1495","article-title":"Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy","volume":"58","author":"Kaunisto","year":"2009","journal-title":"Diabetes"},{"key":"B101","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/jcla.21861","article-title":"Mannose-binding lectin and diabetic nephropathy in type 1 diabetes","volume":"30","author":"Zhao","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e0119699","DOI":"10.1371\/journal.pone.0119699","article-title":"Elevated serum levels of mannose-binding lectin and diabetic nephropathy in type 2 diabetes","volume":"10","author":"Guan","year":"2015","journal-title":"PLoS One"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00125-007-0686-0","article-title":"Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice","volume":"50","author":"\u00d8stergaard","year":"2007","journal-title":"Diabetologia"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00125-010-1742-8","article-title":"Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes","volume":"53","author":"Hansen","year":"2010","journal-title":"Diabetologia"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1001\/archinte.166.18.2007","article-title":"Mannose-binding lectin and mortality in type 2 diabetes","volume":"166","author":"Hansen","year":"2006","journal-title":"Arch Intern Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.2337\/db10-1181","article-title":"Transcriptome analysis of human diabetic kidney disease","volume":"60","author":"Woroniecka","year":"2011","journal-title":"Diabetes"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1007\/s00125-010-1757-1","article-title":"Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury","volume":"53","author":"Lim","year":"2010","journal-title":"Diabetologia"},{"key":"B108","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaut.2008.12.003","article-title":"Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice","volume":"32","author":"Xiao","year":"2009","journal-title":"J Autoimmun"},{"key":"B109","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.cyto.2005.04.006","article-title":"Streptozotocin-induced diabetic nephropathy in rats: the role of inflammatory cytokines","volume":"31","author":"Mensah-Brown","year":"2005","journal-title":"Cytokine"},{"key":"B110","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2337\/diabetes.37.5.507","article-title":"Proteinuria and activated T-lymphocytes in diabetic nephropathy","volume":"37","author":"Bending","year":"1988","journal-title":"Diabetes"},{"key":"B111","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1677\/joe.0.1820145","article-title":"Diabetes induces apoptosis in lymphocytes","volume":"182","author":"Otton","year":"2004","journal-title":"J Endocrinol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000334928","article-title":"Aberrant recruitment and activation of T cells in diabetic nephropathy","volume":"35","author":"Moon","year":"2012","journal-title":"Am J Nephrol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/cs1020069","article-title":"Abnormalities in primary granule exocytosis in neutrophils from type I diabetic patients with nephropathy","volume":"102","author":"Fardon","year":"2002","journal-title":"Clin Sci"},{"key":"B114","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2337\/diacare.23.3.417","article-title":"Increased spontaneous adherence of neutrophils from type 2 diabetic patients with overt proteinuria","volume":"23","author":"Takahashi","year":"2000","journal-title":"Diabetes Care"},{"key":"B115","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1159\/000320749","article-title":"Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure","volume":"32","author":"Kelly","year":"2010","journal-title":"Am J Nephrol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1523-1755.2004.00367.x","article-title":"Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury","volume":"65","author":"Chow","year":"2004","journal-title":"Kidney Int"},{"key":"B117","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1440-1797.2006.00576.x","article-title":"Macrophage accumulation in human progressive diabetic nephropathy","volume":"11","author":"Nguyen","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/ndt\/gfw260","article-title":"Macrophages in diabetic nephropathy in patients with type 2 diabetes","volume":"32","author":"Klessens","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B119","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2337\/db06-0359","article-title":"Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation","volume":"56","author":"Usui","year":"2007","journal-title":"Diabetes"},{"key":"B120","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2337\/diabetes.49.3.466","article-title":"Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats","volume":"49","author":"Sassy-Prigent","year":"2000","journal-title":"Diabetes"},{"key":"B121","doi-asserted-by":"publisher","first-page":"F1358","DOI":"10.1152\/ajprenal.00332.2011","article-title":"Monocyte\/macrophage chemokine receptor CCR2 mediates diabetic renal injury","volume":"301","author":"Awad","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/MNH.0000000000000186","article-title":"Monocyte chemoattractant protein-1 and the kidney","volume":"25","author":"Haller","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B123","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.4049\/jimmunol.163.11.6148","article-title":"Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4","volume":"163","author":"Matsukawa","year":"1999","journal-title":"J Immunol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.ki.5000014","article-title":"Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice","volume":"69","author":"Chow","year":"2006","journal-title":"Kidney Int"},{"key":"B125","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ebiom.2017.04.011","article-title":"Hyperglycemia-induced renal P2X7 receptor activation enhances diabetes-related Injury","volume":"19","author":"Menzies","year":"2017","journal-title":"EBioMedicine"},{"key":"B126","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/ndt\/gfv459","article-title":"C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria","volume":"32","author":"Menne","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B127","doi-asserted-by":"publisher","first-page":"F1288","DOI":"10.1152\/ajprenal.00316.2013","article-title":"CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice","volume":"305","author":"Sullivan","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.atherosclerosis.2012.09.009","article-title":"Neutrophil\/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography","volume":"225","author":"Arbel","year":"2012","journal-title":"Atherosclerosis"},{"key":"B129","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1177\/1076029615569568","article-title":"The relation between atherosclerosis and the neutrophil-lymphocyte ratio","volume":"22","author":"Balta","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"key":"B130","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/0003319715577529","article-title":"Neutrophil to lymphocyte ratio and the extent of coronary artery disease: results from a Large Cohort Study","volume":"67","author":"Verdoia","year":"2015","journal-title":"Angiology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0003319711412763","article-title":"Hematologic parameters and angiographic progression of coronary atherosclerosis","volume":"63","author":"Kalay","year":"2012","journal-title":"Angiology"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/qjmed\/hcs123","article-title":"The long-term predictive value of the neutrophil-to-lymphocyte ratio in type 2 diabetic patients presenting with acute myocardial infarction","volume":"105","author":"Lee","year":"2012","journal-title":"QJM"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cjca.2014.05.010","article-title":"Higher neutrophil\/lymphocyte ratio is related to lower ejection fraction and higher long-term all-cause mortality in ST-elevation myocardial infarction patients","volume":"30","author":"Arbel","year":"2014","journal-title":"Can J Cardiol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/0003319712455216","article-title":"Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population: a 4-year follow-up study","volume":"64","author":"Azab","year":"2013","journal-title":"Angiology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/1076029612475023","article-title":"Higher neutrophil to lymhocyte ratio in patients with metabolic syndrome","volume":"19","author":"Balta","year":"2013","journal-title":"Clin Appl Thromb Hemost"},{"key":"B136","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/1076029612459675","article-title":"Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome","volume":"20","author":"Buyukkaya","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"B137","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1055\/s-0035-1547257","article-title":"Nephropathy, but not angiographically proven retinopathy, is associated with neutrophil to lymphocyte ratio in patients with type 2 diabetes","volume":"123","author":"Ciray","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B138","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1586\/14779072.2014.902309","article-title":"Neutrophil-lymphocyte ratio as an important assessment tool","volume":"12","author":"Balta","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jacc.2005.02.054","article-title":"Which white blood cell subtypes predict increased cardiovascular risk?","volume":"45","author":"Horne","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/0886022X.2011.641514","article-title":"The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients","volume":"34","author":"Turkmen","year":"2012","journal-title":"Ren Fail"},{"key":"B141","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/0886022X.2012.734429","article-title":"Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease","volume":"35","author":"Okyay","year":"2013","journal-title":"Ren Fail"},{"key":"B142","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5301\/jn.5000152","article-title":"Role of neutrophil\/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease","volume":"26","author":"Kocyigit","year":"2013","journal-title":"J Nephrol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1089\/dia.2013.0264","article-title":"Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes","volume":"16","author":"Shiny","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"B144","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3275\/8894","article-title":"Is there a link between neutrophil-lymphocyte ratio and microvascular complications in geriatric diabetic patients?","volume":"36","author":"Ozturk","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"B145","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1089\/dia.2013.0097","article-title":"Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy","volume":"15","author":"Ulu","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"B146","first-page":"1794","article-title":"Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy","volume":"7","author":"Akbas","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"B147","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/cen.12576","article-title":"Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy","volume":"82","author":"Huang","year":"2015","journal-title":"Clin Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00225\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T15:07:53Z","timestamp":1693667273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00225\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":147,"alternative-id":["10.3389\/fendo.2018.00225"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00225","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"article-number":"225"}}